FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Creo Medical Group's FCF Yield % or its related term are showing as below:
FRA:1RC'
s FCF Yield % Range Over the Past 10 Years
Min: -81.53 Med: -33.56 Max: -4.83
Current: -30.5
During the past 11 years, the highest FCF Yield % of Creo Medical Group was -4.83%. The lowest was -81.53%. And the median was -33.56%.
FRA:1RC's FCF Yield % is ranked worse than 87.59% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs FRA:1RC: -30.50
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Creo Medical Group FCF Yield % Related Terms
Creo Medical Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for Creo Medical Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Creo Medical Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creo Medical Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Creo Medical Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creo Medical Group (FRA:1RC) has a FCF Yield % of -30.50 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Creo Medical Group and its competitors. According to the industry distribution chart, Creo Medical Group ranks #748 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 87.6%.
Is Creo Medical Group's FCF Yield % too high?
Creo Medical Group's current FCF Yield % is -30.50. Based on the distribution chart, Creo Medical Group ranks #748 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Creo Medical Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Creo Medical Group ranks #748 out of 854 companies for FCF Yield %. This places Creo Medical Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Creo Medical Group and its competitors. Creo Medical Group's current FCF Yield % is -30.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Creo Medical Group (FRA:1RC) has a current FCF Yield % of -30.50. The stock's GF Value™ is €0.18, compared to a current price of €0.15 — trading 19.4% below its estimated fair value. The current FCF Yield % is -30.50. Creo Medical Group's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Creo Medical Group (FRA:1RC), the current FCF Yield % is -30.50 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creo Medical Group (FRA:1RC) Overvalued in 2026?
Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued.
The current stock price of €0.15 is trading 19.4% below its estimated GF Value™ of €0.18.
Key valuation signals for FRA:1RC:
FCF Yield %: -30.50
GF Value™: €0.18 vs. price of €0.15 (19.4% below fair value)
No single metric tells the full story. See the FRA:1RC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
53GF Score
Get the complete analysis for FRA:1RC
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1RC has been successfully added to your 
